The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the protective effect and safety of soluble
beta-1,3/1,6-glucan compared to placebo in oral mucositis in head and neck patients receiving
radiotherapy or chemoradiotherapy.
Hypothesis: Soluble beta-1,3/1,6-glucan will through its immunomodulating activities prevent
oral mucositis